| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in REPL over the last quarter tilts toward selling: insiders offloaded a net 79,124 shares worth roughly $1.0M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.36M | $28.13M | - | |
| CEO | 708.2K | $14.62M | - | |
| Other | 224.2K | $4.63M | - | |
| CFO | 215.9K | $4.46M | - | |
| Other | 181.0K | $3.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | Konstantinos Xynos54 | Chief Medical Officer | Sell | 7,952 | $8.06 | $64,093.12 | -5.1% | -42.0% | -43.9% | |
| May 20, 2025 | Andrew Schwendenman | Chief Accounting Officer | Sell | 3,287 | $8.05 | $26,460.35 | -4.6% | -42.0% | -43.9% | |
| May 20, 2025 | Sushil Patel64 | Chief Executive Officer | Sell | 25,105 | $8.06 | $202,346.30 | -6.8% | -42.0% | -43.9% | |
| May 20, 2025 | Emily Luisa Hill59 | Chief Financial Officer | Sell | 2,535 | $8.05 | $20,406.75 | -1.7% | -42.0% | -43.9% | |
| Dec 16, 2024 | Sushil Patel64 | Chief Executive Officer | Sell10b5-1 | 10,000 | $12.42 | $124,200.00 | -4.7% | -5.6% | -23.0% | |
| Nov 18, 2024 | Konstantinos Xynos54 | Chief Medical Officer | Sell | 7,246 | $10.78 | $78,111.88 | -6.2% | +30.3% | -18.8% | |
| Nov 18, 2024 | Christopher Sarchi55 | Chief Commercial Officer | Sell | 5,207 | $10.78 | $56,131.46 | -5.6% | +30.3% | -18.8% | |
| Aug 16, 2024 | Emily Luisa Hill59 | Chief Financial Officer | Sell | 8,938 | $10.18 | $90,988.84 | -8.1% | +12.8% | -45.0% | |
| Jun 7, 2024 | Konstantinos Xynos54 | Chief Medical Officer | Sell10b5-1 | 15,881 | $7.50 | $119,107.50 | -11.9% | +35.7% | +31.4% | |
| May 16, 2024 | Christopher Sarchi55 | Chief Commercial Officer | Sell | 2,218 | $6.47 | $14,350.46 | -2.3% | +46.7% | +16.8% |